Discovery phase bioanalysis including rapid screening, non-GLP bioanalysis tailored to support your early stage drug development and lead optimization
Intertek provides three 'standard' modes of LC-MS/MS bioanalytical support for drug discovery based upon your requirements. A dedicated LC-MS/MS discovery project team typically delivers data within 5 days after sample receipt, given one-week of advance notice.
Mode I - Rapid Discovery Screen
Mode II – Lead Optimization (non-GLP early Pharmacokinetic (PK) studies)
Mode III – Lead Qualification (bridging and non-GLP toxicokinetic studies)
Need help or have a question?